Press releases
- Haemonetics Announces Proposed Convertible Senior Notes Offering
- Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
- Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
- Haemonetics Corporation Completes Acquisition of Attune Medical
- Haemonetics Announces Definitive Agreement to Acquire Attune Medical
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 81.50 |
---|---|
High | 81.50 |
Low | 81.50 |
Bid | 82.50 |
Offer | 84.50 |
Previous close | 81.50 |
Average volume | 27.00 |
---|---|
Shares outstanding | 50.79m |
Free float | 50.37m |
P/E (TTM) | 40.74 |
Market cap | 4.73bn USD |
EPS (TTM) | 2.29 USD |
Data delayed at least 15 minutes, as of May 22 2024 07:10 BST.
More ▼